Target intelligence / Profile preview

Multiple extracellular matrix components, growth factors, and cytokines

Molecular classification
Extracellular matrix protein, Growth factor, Cytokine, Signaling molecule
01

Overview

The term Multiple extracellular matrix components, growth factors, and cytokines refers to the diverse collection of proteins and signaling molecules that constitute the cellular microenvironment. The extracellular matrix (ECM) provides the essential physical scaffold for tissues and transmits biochemical signals that regulate cell adhesion, migration, and survival (Source: NIH National Cancer Institute). Growth factors and cytokines are secreted proteins that act as critical chemical messengers, mediating intercellular communication to drive processes such as cell proliferation, tissue repair, and immune activation (Source: PubMed 25497013). In various disease states, such as cancer and chronic inflammation, the balance of these components is often disrupted, leading to pathological tissue remodeling and sustained disease progression (Source: Nature Reviews Cancer). Because this description encompasses hundreds of distinct molecular entities with varying functions, it is classified as a broad category rather than a specific, druggable molecular target. Pharmacological interventions typically focus on individual components within this group, such as using monoclonal antibodies to neutralize specific cytokines like TNF-alpha or growth factors like VEGF (Source: StatPearls).

Other names
Extracellular matrixGrowth factorsCytokinesCellular microenvironmentSecretomeTumor microenvironment components
02

Mechanism of action

Neutralization of secreted signaling proteins, blockade of their respective receptors, or modulation of extracellular matrix deposition and enzymatic remodeling.

03

Biological functions

Cell signalingStructural supportCell adhesionImmune responseCell proliferationTissue remodeling
04

Disease associations

CancerInflammationFibrosisCardiovascular diseaseAutoimmune disease
05

Safety considerations

Systemic immunosuppressionImpaired wound healingOff-target signaling disruptionIncreased risk of opportunistic infectionsTissue toxicity
06

Interacting drugs

Bevacizumab

5 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Vascular endothelial growth factor (VEGF) levelsInterleukin-6 (IL-6) levelsMatrix metalloproteinases (MMPs)Tumor necrosis factor (TNF) levels

Beyond the preview

Go deeper on Multiple extracellular matrix components, growth factors, and cytokines.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple extracellular matrix components, growth factors, and cytokines.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call